Singapore: Hummingbird Bioscience, an innovative biotechnology company focused on the discovery and early development of...
Singapore: China's clinical-stage biopharmaceutical company, Ascentage Pharma, announced collaboration with San Francisc...
Singapore: According to a Chinese news agency, the country's regulators have approved a domestically developed experimen...
Singapore: A recent report by the Chinese national media has claimed that gutter oil is being used to make antibiotics, ...
Singapore: China State Food & Drug Administration (SFDA) has approved CellSearch, circulating tumor cell (CTC) test ...
Singapore: Global drug giant Pfizer has recently announced plans to invest $350 mn to build a Global Biotechnology Cente...
Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bo...
Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori...
Singapore: With the objective to promote high-end medical equipment localization, China is holding MEDTEC China 2014 sum...
Singapore: MMRGlobal announced that through its China joint venture, Unis-Tonghe MMR International Health Management Ser...
Singapore: US-based Colorcon, a world leader in offering development, supply and technical support to the pharmaceutical...
Singapore: Chinese drugmaker Shanghai Pharma and private equity firm Primavera capital recently announced their plans to...
Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attr...
Singapore: Hosted by the UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo, this year's CPhI China will be conducte...
Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mo...
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...
Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein...
